Moleculin Biotech (MOL) Q2 2026 Earnings Report
DE:MOL Q2 2026 EPS Results
- Actual EPS
- -EUR 25.07
- Consensus EPS
- -EUR 27.82
- Beat/Miss
- Beat by +EUR 2.75
- One Year Ago EPS
- -EUR 219.37
DE:MOL Q2 2026 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/14/2026
- Time
- Before Open
- Conference Call
- Friday, August 14, 2026
DE:MOL Upcoming Earnings
Moleculin Biotech's next earnings date is estimated for March 19, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:MOL Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 19, 2027 | 2026 (Q4) | ―- | 2.34 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | -27.82-25.07 | -219.37 | 88.57% (+194.30) | |
| May 15, 2026 | 2026 (Q1) | -41.79-63.39 | -308.91 | 79.48% (+245.52) | |
| Mar 19, 2026 | 2025 (Q4) | -109.4846.74 | 111.92 | -58.24% (-65.18) | |
| Nov 17, 2025 | 2025 (Q3) | -5.89-15.24 | -63.8 | 76.12% (+48.56) | |
| Aug 13, 2025 | 2025 (Q2) | -192.51-219.37 | -761.09 | 71.18% (+541.72) | |
| May 14, 2025 | 2025 (Q1) | -248.47-308.91 | -904.35 | 65.84% (+595.44) | |
| Mar 24, 2025 | 2024 (Q4) | -574.55111.92 | -2247.45 | 104.98% (+2359.37) | |
| Nov 11, 2024 | 2024 (Q3) | -1092.39-1275.94 | -1275.94 | 0.00% (+0.00) | |
| Aug 14, 2024 | 2024 (Q2) | -1123.72-761.09 | -1343.1 | 43.33% (+582.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
